BNGO•benzinga•
Bionano Preliminary Revenue For Q4 2024 Expected Between $7.9M-$8.1M Despite 25% Decrease; Optical Genome Mapping Systems Increase By 14% To 371 Units; Nanochannel Array Flowcells Sales Rise 1% To 8,058 Units
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga